Conceptual evolution in the relationship between Graves' ophthalmopathy and thyroidal Graves' disease

References

• Adams D. D., Fastier F. N., Howie J. B., Kennedy T. H., Kilpatrick J. A., Stewart R. D. H. Stimulation of the human thyroid by infusions of plasma containing LATS-protector. J. din. Endocr. Metab. 1974; 39: 826
   PubMedGoogle Scholar
• Amino N., Yuasa T., Yabu Y., Miyai K., Kumahara Y. Exophthalmos in autoimmune thyroid disease. J. din. Endocr. Metab. 1980; 51: 1232
   PubMed Web of Science ®Google Scholar
• Arnaud C. D., Kneubuhler H. A., Seiling V. L., Wightmen B. K., Engbring N. H. Responses of the normal human to infusions of plasma from patients with Graves' disease. J. din. Invest. 1965; 44: 1287
   Google Scholar
• Atkinson S., Holcombe M., Kendall-Taylor P. Ophthalmopathic immunoglobulin in patients with Graves' ophthalmopathy. Lancet 1984; ii: 374
   Google Scholar
• Bech K., Lumholtz B., Nerup J., Thomsen M., Platz P., Ryder L. R., Svejgaard A., Siersboek-Nielsen K., Molholm Hansen J., Larsen J. H. HLA antigens in Graves' disease. Acta endocr. (Kbh.) 1977; 86: 510
   PubMedGoogle Scholar
• Brownlie B. E. W., Newton O. A. G., Singh S. P. Ophthalmopathy associated with primary hypothyroidism. Acta endocr. (Kbh.) 1975; 79: 691
   Google Scholar
• Christy J. H., Morse R. S. Hypothyroid Graves' disease. Amer. J. Med. 1977; 62: 291
   Google Scholar
• Day R. M. Extraocular muscle problems associated with Graves' disease: clinical evaluation and diagnosis. Ophthalmology 1979; 86: 2051
   Google Scholar
• De Lange G. J., Van Der Gaag R. D., Van Der Gaag R., De Vries R. P., Drexhage H. A. Immunoglobulin allotypes and HLA in thyroid autoimmune disease (abstract). Ann. Endocr. (Paris) 1984; 45: 81
   Google Scholar
• Drexhage H. A., Bottazzo G. F., Doniach D., Bitensky L., Chayen J. Evidence for thyroid-growth-stimulating immunoglobulins in some goitrous thyroid diseases. Lancet 1980; ii: 287
   Google Scholar
• Drexhage H. A., Bottazzo G. F., Bitensky L., Chayen J., Doniach D. Thyroid-growth-blocking antibodies in primary myxoedema. Nature 1981; 289: 594
   PubMedGoogle Scholar
• Enzmann D. R., Donaldson S. S., Kriss J. P. Appearance of Graves' disease on orbital computed tomography. Comp. assist. Tomogr. 1979; 3: 815
   PubMed Web of Science ®Google Scholar
• Farid N. R., Sampson L., Noel E. P., Barnard J. M., Mandeville R., Larsen B., Marshall W. H., Carter M. D. A study of human leucocyte D locus related antigens in Graves' disease. J. din. Invest. 1979; 63: 108
   PubMed Web of Science ®Google Scholar
• Farid N. R., Stone E., Johnson G. Graves' disease and HLA clinical and epidemiological associations. Clin. Endocr. 1980; 13: 535
   PubMed Web of Science ®Google Scholar
• Farid N. R., Bear J. C. The human major histocompatibility complex and endocrine disease. Endocr. Rev. 1981; 2: 50
   Google Scholar
• Forrester J V., Sutherland G. R., McDougall J. R. Dysthyroid ophthalmopathy: orbital evaluation with B-scan ultrasonography. J. clin. Endocr. Metab. 1977; 45(221)
   Google Scholar
• Franco P. S., Hershman J. M., Haigler E. D. Response to thyrotropin-releasing hormone compared with thyroid suppression tests in euthyroid Graves' disease. Metabolism 1973; 22: 1357
   Google Scholar
• Gamblin G. T., Harper D. G., Galentine P., Buck D. R., Chernow B., Eil C. Prevalence of increased intraocular pressure in Graves' disease: evidence of frequent subclinical ophthalmopathy. New Engl. J. Med. 1983; 308: 420
   PubMed Web of Science ®Google Scholar
• Gorman C. A. Ophthalmopathy of Graves' disease. New Engl. J. Med. 1983a; 308: 453
   Google Scholar
• Gorman C. A. Temporal relationship between onset Graves' ophthalmopathy and diagnosis of thyrotoxicosis. Mayo Clin. Proc. 1983b; 55: 515
   Google Scholar
• Hall R., Doniach D., Kirkham K., Elkabir D. Ophthalmic Graves' disease. Lancet 1970; i: 375
   Google Scholar
• Ivy H. K. Medical approach to ophthalmopathy of Graves' disease. Mayo Clin. Proc. 1972; 47: 980
   PubMed Web of Science ®Google Scholar
• Jacobson D. H., Gorman C. A. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis and treatment. Endocr. Rev. 1984; 5: 200
   PubMed Web of Science ®Google Scholar
• Kendall-Taylor P., Atkinson S., Holcombe M. A specific IgG in Graves' ophthalmopathy and its relation to retroorbital and thyroid autoimmunity. Brit. med. J. 1984; 288: 1183
   PubMed Web of Science ®Google Scholar
• Kodama K., Sikorska H., Bandy-Dafoe P., Bayly R., Wall J. R. Demonstration of a circulating autoantibody against soluble eye-muscle antigen in Graves' ophthalmopathy. Lancet 1982; ii: 1353
   Google Scholar
• Kriss J. P., Konishi J., Herman M. Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy). Rec. Progr. Horm. Res. 1975; 31: 533
   PubMedGoogle Scholar
• Kuroki T., Whelan L., Wall J. R. A possible role of autoimmunity against orbital tissue-thyroid shared antigens in Graves' ophthalmopathy (abstract). Ann. Endocr. (Paris) 1984; 45: 13
   Google Scholar
• Lawton N. F., Fells P., Lloyd G. A. S. Medical investigation of dysthyroid eye disease. Proceedings of the 3rd International Symposium on Orbital Disorders. W. Junk, The Hague 1978; 343
   Google Scholar
• Milgrom F., Witebsky E. Autoantibodies and auto-immune diseases. J. Amer. med. Ass. 1962; 181: 106
   Google Scholar
• Munro R. E., Lamki L., Row V. V., Volpe R. Cell-mediated immunity in the exophthalmos of Graves' disease as demonstrated by the migration of inhibition factor (MIF) test. J. clin. Endocr. Metab. 1973; 57: 286
   Google Scholar
• Orgiazzi J., Williams D. E., Chopra I., Solomon D. H. Human thyroid adenylcyclase stimulating activity in immunoglobulin G of patients with Graves' disease. J. clin. Endocr. Metab. 1976; 42: 341
   PubMedGoogle Scholar
• Ormston B. J., Alexander L., Evered D. C, Clark F., Bird T., Appleton D., Hall R. Thyrotrophin response to thyrotrophin-releasing hormone in ophthalmic Graves' disease: correlation with other aspects of thyroid function, thyroid suppressibility, and activity of eye signs. Clin. Endocr. 1973; 2: 369
   Google Scholar
• Otter R., Wiersinga W. M., Peeters H. J. F., Bleeker G. M., Touber J. L. Experience with the thyrotrophin releasing hormone (TRH) test in the diagnosis of Graves' ophthalmopathy. Ned. T. Geneesk. 1982; 126: 2189
   Google Scholar
• Schernthaner G., Ludwig H., Mayr W. R., Hofer R. Genetic heterogeneity in thyrotoxicosis patients with and without endocrine ophthalmopathy. Diabetes Metab. 1977; 3: 189
   Google Scholar
• Solomon D. H., Chopra I. J., Chopra U., Smith F. J. Identification of subgroups of euthyroid Graves' ophthalmopathy. New Engl. J. Med. 1977; 296: 181
   PubMed Web of Science ®Google Scholar
• Tam Ai H., Nakag Aw A T., Ohsako N., Fukino O., Takahashi H., Matsuzuka F., Kuma K., Nagatak1 S. Changes in thyroid functions in patients with euthyroid Graves' disease. J. clin. Endocr. Metab. 1980; 50: 108
   Google Scholar
• Teng C. S., Smith B. R., Clayton B., Evered D. C, Clark F., Hall R. Thyroid-stimulating immunoglobulins in ophthalmic Graves' disease. Clin. Endocr. 1977; 6: 207
   PubMedGoogle Scholar
• Valente W. A., Vitti P., Yavin E. Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves' disease. Proc. nat. Acad. Sci. USA 1982; 79: 6680
   PubMed Web of Science ®Google Scholar
• Valente W. A., Vitti P., Rotella C. M., Vaughan M. M., Aloj S. M., Grollman E. F., Ambesi-Impiombata F. S., Kohn L. D. Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies. New Engl. J. Med. 1983; 309: 1028
   PubMed Web of Science ®Google Scholar
• Werner S. C, Feind C. R., Aida M. Graves' disease and total thyroidectomy: progression of severe eye changes and decrease in serum long acting thyroid stimulator after operation. New Engl. J. Med. 1967; 276: 132
   PubMedGoogle Scholar
• Werner S. C, Coleman D. J., Franzen L. A. Ultrasonographic evidence of a consistent orbital involvement in Graves' disease. New Engl. J. Med. 1974; 290: 1447
   PubMed Web of Science ®Google Scholar
• Werner S. C. Modification of the classification of the eye changes of Graves' disease: recommendations of the ad hoc committee of the American Thyroid Association. J. din. Endocr. Metab. 1977; 44: 203
   PubMed Web of Science ®Google Scholar
• Yamamoto K., Itoh K., Yoshida S., Saito K., Sakamoto Y., Matsuda A., Saito T., Kuzuya T. A quantitative analysis of orbital soft tissue in Graves' disease based on B-mode ultrasonography. Endocr. Jap. 1979; 26: 255
   Google Scholar